Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HUMIRA® Special Investigation (Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis)

NCT02916017 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02916017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02916017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HUMIRA® Special Investigation (Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
November 15, 2016
Completion date
October 14, 2020
Enrollment
259 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

uveitis